Search
for
Sort by
Research 151–180 of 532
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- The role of lymphocytes in the development and treatment of alopecia areata
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Emerging treatments in alopecia
- Identification of potential key genes and pathways associated with the Pashmina fiber initiation using RNA-Seq and integrated bioinformatics analysis
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- 3-Deoxysappanchalcone Promotes Proliferation of Human Hair Follicle Dermal Papilla Cells and Hair Growth in C57BL/6 Mice by Modulating WNT/β-Catenin and STAT Signaling
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Hair Growth Stimulation Effect of Centipeda minima Extract: Identification of Active Compounds and Anagen-Activating Signaling Pathways
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- MSC-EVs and UCB-EVs promote skin wound healing and spatial transcriptome analysis
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Transcriptional Profiling in Rat Hair Follicles following Simulated Blast Insult: A New Diagnostic Tool for Traumatic Brain Injury
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Novel therapies for alopecia areata: The era of rational drug development
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- An updated review of the sebaceous gland and its role in health and diseases Part 2: Pathophysiological clinical disorders of sebaceous glands
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- 1310 Anti-aging effects of retinoid hydroxypinacolone retinoate on skin models
- Oxidative stress and alopecia areata
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata